Craft

Simcha Therapeutics

Total Funding

$25 M

Simcha Therapeutics Summary

Company Summary

Overview
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer. Its technology uses directed evolution to engineer novel cytokines designed to unlock the precision and power of the immune system, enabling patients to fight diseases with the immune system.
Type
Private
Status
Active
Founded
2018
Website
https://www.simchatx.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu